The Defense Logistics Agency (DLA) awarded a $6,175.01 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,753,870 units of Dupixent 300 mg/2 ml pens. This contract, which does not have a set-aside designation, has an ultimate completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these critical pharmaceutical products to support various military treatment facilities and federal healthcare programs. This contract is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at up to $999,999,999 and runs through December 2025. The company also holds an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for the delivery of medical products and prescription drugs.
Generated 12/10/24, 2:18 PM